Literature DB >> 28117360

Barrett's Esophagus With Low-Grade Dysplasia: Ablate or Wait?

Sravanthi Parasa1, Prateek Sharma2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28117360     DOI： 10.1038/ajg.2016.605

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

Review 1.  Clinical practice. Barrett's esophagus.

Authors:  Prateek Sharma
Journal:  N Engl J Med       Date:  2009-12-24       Impact factor: 91.245

Review 2.  Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.

Authors:  John M Inadomi
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-12-18       Impact factor: 3.043

Review 3.  Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review.

Authors:  Bashar J Qumseya; Haibo Wang; Nicole Badie; Rosemary N Uzomba; Sravanthi Parasa; Donna L White; Herbert Wolfsen; Prateek Sharma; Michael B Wallace
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

4.  Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.

Authors:  Wouter L Curvers; Fiebo J ten Kate; Kausilia K Krishnadath; Mike Visser; Brenda Elzer; Lubertus C Baak; Clarisse Bohmer; Rosalie C Mallant-Hent; Arnout van Oijen; Anton H Naber; Pieter Scholten; Olivier R Busch; Harriët G T Blaauwgeers; Gerrit A Meijer; Jacques J G H M Bergman
Journal:  Am J Gastroenterol       Date:  2010-05-11       Impact factor: 10.864

5.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Authors:  E Montgomery; M P Bronner; J R Goldblum; J K Greenson; M M Haber; J Hart; L W Lamps; G Y Lauwers; A J Lazenby; D N Lewin; M E Robert; A Y Toledano; Y Shyr; K Washington
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

Review 6.  Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Palaniappan Manickam; Anita V Amin; Niharika Samala; Leo J Schouten; Prasad G Iyer; Tusar K Desai
Journal:  Gastrointest Endosc       Date:  2014-02-17       Impact factor: 9.427

7.  DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.

Authors:  Muhammad A Alvi; Xinxue Liu; Maria O'Donovan; Richard Newton; Lorenz Wernisch; Nicholas B Shannon; Kareem Shariff; Massimiliano di Pietro; Jacques J G H M Bergman; Krish Ragunath; Rebecca C Fitzgerald
Journal:  Clin Cancer Res       Date:  2012-12-14       Impact factor: 12.531

8.  Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.

Authors:  Christine Kestens; G Johan A Offerhaus; Jantine W P M van Baal; Peter D Siersema
Journal:  Clin Gastroenterol Hepatol       Date:  2015-12-31       Impact factor: 11.382

9.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

10.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

Authors:  K Nadine Phoa; Frederike G I van Vilsteren; Bas L A M Weusten; Raf Bisschops; Erik J Schoon; Krish Ragunath; Grant Fullarton; Massimiliano Di Pietro; Narayanasamy Ravi; Mike Visser; G Johan Offerhaus; Cees A Seldenrijk; Sybren L Meijer; Fiebo J W ten Kate; Jan G P Tijssen; Jacques J G H M Bergman
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.